Beyond usual functions of snoRNAs;Les petits ARN nucléolaires nous surprennent encore !

Medecine/Sciences

Volumn 30, Issue 3, 2014, Pages 297-302

  Abel, Yoann ^a   Clerget, Guillaume ^a   Bourguignon Igel, Valérie ^a   Salone, Véronique ^a   Rederstorff, Mathieu ^a  

^a UNIVERSITÉ DE LORRAINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME; MESSENGER RNA; RNA PRECURSOR; SMALL NUCLEOLAR RNA;

ANIMAL; ARTICLE; GENETICS; HUMAN; METABOLISM; NEOPLASM; PHYSIOLOGY; PROTEIN TRANSPORT;

ANIMALS; ENZYMES; HUMANS; NEOPLASMS; PROTEIN TRANSPORT; RNA PRECURSORS; RNA, MESSENGER; RNA, SMALL NUCLEOLAR;

EID: 84897499517     PISSN: 07670974     EISSN: 19585381     Source Type: Journal    
DOI: 10.1051/medsci/20143003018     Document Type: Article

References (45)

1. Rederstorff M. Une approche originale de sélection de nouveaux ARN non codants. Med Sci (Paris) 2011; 27: 343-345.
2. Cavaille J. Des microARN comme s'il en pleuvait Med Sci (Paris) 2004; 20: 399-401.
3. Kawaji H, Nakamura M, Takahashi Y, et al. Hidden layers of human small RNAs. BMC Genomics 2008; 9: 157.
4. Ender C, Krek A, Friedlander MR, et al. A human snoRNA with microRNA-like functions. Mol Cell 2008; 32: 519-528.
5. Saraiya AA, Wang CC., snoRNA, a novel precursor of microRNA in Giardia lamblia. PLoS Pathog 2008; 4: e1000224.
6. Taft RJ, Glazov EA, Lassmann T, et al. Small RNAs derived from snoRNAs. RNA 2009; 15: 1233-1240.
7. Brameier M, Herwig A, Reinhardt R, et al. Human box C/D snoRNAs with miRNA like functions: expanding the range of regulatory RNAs. Nucleic Acids Res 2011; 39: 675-686.
8. Kishore S, Gruber AR, Jedlinski DJ, et al. Insights into snoRNA biogenesis, processing from PAR-CLIP of snoRNA core proteins, small RNA sequencing. Genome Biol 2013; 14: R45.
9. Scott MS, Ono M. From snoRNA to miRNA: Dual function regulatory non-coding RNAs. Biochimie 2011; 93: 1987-1992.
10. Iwasaki S, Kobayashi M, Yoda M, et al. Hsc70/Hsp90 chaperone machinery mediates ATP-dependent RISC loading of small RNA duplexes. Mol Cell 2010; 39: 292-299.
11. Cavaille J, Buiting K, Kiefmann M, et al. Identification of brain-specific and imprinted small nucleolar RNA genes exhibiting an unusual genomic organization. Proc Natl Acad Sci USA 2000; 97: 14311-14316.
12. Rederstorff M, Huttenhofer A. Small non-coding RNAs in disease development and host-pathogen interactions. Curr Opin Mol Ther 2010; 12: 684-694.
13. Vitali P, Cavaille J. Petits ARN C/D et syndrome de Prader-Willi. Med Sci (Paris) 2005; 21: 1017-1019.
14. De Smith AJ, Purmann C, Walters RG, et al. A deletion of the HBII-85 class of small nucleolar RNAs (snoRNAs) is associated with hyperphagia, obesity and hypogonadism. Hum Mol Genet 2009; 18: 3257-3265.
15. Duker AL, Ballif BC, Bawle EV, et al. Paternally inherited microdeletion at 15q11.2 confirms a significant role for the SNORD116 C/D box snoRNA cluster in Prader-Willi syndrome. Eur J Hum Genet 2010; 18: 1196-1201.
16. Sahoo T, del Gaudio D, German JR, et al. Prader-Willi phenotype caused by paternal deficiency for the HBII-85 C/D box small nucleolar RNA cluster. Nat Genet 2008; 40: 719-721.
17. Schaaf CP, Gonzalez-Garay ML, Xia F, et al. Truncating mutations of MAGEL2 cause Prader-Willi phenotypes and autism. Nat Genet 2013; 45: 1405-1408.
18. Kishore S, Stamm S. The snoRNA HBII-52 regulates alternative splicing of the serotonin receptor 2C. Science 2006; 311: 230-232.
19. Bortolin-Cavaille ML, Cavaille J. The SNORD115 (H/MBII-52) and SNORD116 (H/MBII-85) gene clusters at the imprinted Prader-Willi locus generate canonical box C/D snoRNAs. Nucleic Acids Res 2012; 40: 6800-6807.
20. Kishore S, Khanna A, Zhang Z, et al. The snoRNA MBII-52 (SNORD 115) is processed into smaller RNAs and regulates alternative splicing. Hum Mol Genet 2010; 19: 1153-1164.
21. Rederstorff M, Bernhart SH, Tanzer A, et al. RNPomics: defining the ncRNA transcriptome by cDNA library generation from ribonucleo-protein particles. Nucleic Acids Res 2010; 38: e113.
22. Scott MS, Ono M, Yamada K, et al. Human box C/D snoRNA processing conservation across multiple cell types. Nucleic Acids Res 2012; 40: 3676-3688.
23. Kahn A. L'impérialisme des micro-ARN s'étend maintenant au cancer. Med Sci (Paris) 2005; 21: 687-689.
24. Ladeiro Y, Zucman-Rossi J. Micro-ARN (miARN) et cancer: le cas des tumeurs hépatocellulaires. Med Sci (Paris) 2009; 25: 467-472.
25. Liao J, Yu L, Mei Y, et al. Small nucleolar RNA signatures as biomarkers for non-small-cell lung cancer. Mol Cancer 2010; 9: 198.
26. Zhang L, Yang M, Marks P, et al. Serum non-coding RNAs as biomarkers for osteoarthritis progression after ACL injury. Osteoarthritis Cartilage 2012; 20: 1631-1637.
27. Martens-Uzunova ES, Olvedy M, Jenster G. Beyond microRNA-Novel RNAs derived from small non-coding RNA and their implication in cancer. Cancer Lett 2013; 340: 201-211.
28. Su H, Xu T, Ganapathy S, et al. Elevated snoRNA biogenesis is essential in breast cancer. Oncogene 2013; doi: 10.1038/onc.2013.89.
29. Teittinen KJ, Laiho A, Uusimaki A, et al. Expression of small nucleolar RNAs in leukemic cells. Cell Oncol (Dordr) 2013; 36: 55-63.
30. Valleron W, Ysebaert L, Berquet L, et al. Small nucleolar RNA expression profiling identifies potential prognostic markers in peripheral T-cell lymphoma. Blood 2013; 120: 3997-4005.
31. Williams GT, Farzaneh F. Are snoRNAs and snoRNA host genes new players in cancer? Nat Rev Cancer 2012; 12: 84-88.
32. Dong XY, Guo P, Boyd J, et al. Implication of snoRNA U50 in human breast cancer. J Genet Genomics 2009; 36: 447-454.
33. Dong XY, Rodriguez C, Guo P, et al. SnoRNA U50 is a candidate tumor-suppressor gene at 6q14.3 with a mutation associated with clinically significant prostate cancer. Hum Mol Genet 2008; 17: 1031-1042.
34. Soeno Y, Fujita K, Kudo T, et al. Generation of a mouse model with down-regulated U50 snoRNA (SNORD50) expression, its organ-specific phenotypic modulation. PLoS One 2013; 8: e72105.
35. Mei YP, Liao JP, Shen J, et al. Small nucleolar RNA 42 acts as an oncogene in lung tumorigenesis. Oncogene 2011; 31: 2794-2804.
36. Belin S, Beghin A, Solano-Gonzalez E, et al. Dysregulation of ribosome biogenesis, translational capacity is associated with tumor progression of human breast cancer cells. PLoS One 2009; 4: e7147.
37. Buffa FM, Camps C, Winchester L, et al. microRNA-associated progression pathways and potential therapeutic targets identified by integrated mRNA and microRNA expression profiling in breast cancer. Cancer Res 2011; 71: 5635-5645.
38. Husted S, Sokilde R, Rask L, et al. MicroRNA expression profiles associated with development of drug resistance in Ehrlich ascites tumor cells. Mol Pharm 2011; 8: 2055-2062.
39. Susuki D, Kimura S, Naganuma S, et al. Regulation of microRNA expression by hepatocyte growth factor in human head and neck squamous cell carcinoma. Cancer Sci 2011; 102: 2164-2171.
40. Song B, Wang Y, Xi Y, et al. Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells. Oncogene 2009; 28: 4065-4074.
41. Lee JJ, Drakaki A, Iliopoulos D, Struhl K. MiR-27b targets PPARgamma to inhibit growth, tumor progression and the inflammatory response in neuroblastoma cells. Oncogene 2011; 31: 3818-3825.
42. Eddy SR. Non-coding RNA genes and the modern RNA world. Nat Rev Genet 2001; 2: 919-929.
43. Ono M, Scott MS, Yamada K, et al. Identification of human miRNA precursors that resemble box C/D snoRNAs. Nucleic Acids Res 2011; 39: 3879-3891.
44. Scott MS, Avolio F, Ono M, et al. Human miRNA precursors with box H/ACA snoRNA features. PLoS Comput Biol 2009; 5: e1000507.
45. Dunoyer P. La bataille du silence. Med Sci (Paris) 2009; 25: 505-512.